MedPath

First in-human study on the Safety, Tolerability and Efficacy of the Aqua Medical focal vapor ablation system, for the eradication of Barrett*s Esophagus

Phase 2
Completed
Conditions
Esophageal Carcinoma
Intestinal Metaplasia
10017990
10017987
Registration Number
NL-OMON49629
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

a. Subject is between 22 * 85 years of age.
b. Subject should have Barrett esophagus, with either:
I. Barrett esophagus, circumferential extent * 2 cm or tongues * 3 cm,
with an indication for ablation therapy, either:
i. Flat low grade dysplasia (LGD)
ii. Flat high grade dysplasia (HGD)
iii. Residual Barrett after removal of visible lesions, containing any
grade of dysplasia, or early adenocarcinoma
amendable for endoscopic treatment (mucosal or superficial
submucosal disease, with well to moderately
differentiation and without lymphovascular invasion).
II. Barrett esophagus with a visible lesion with a type 0-IIa, -IIb or -IIc
component, requiring endoscopic resection
c. Hiatal Hernia < 10cm
d. Subject has signed the informed consent form and is able to adhere to study
visit schedule.

Exclusion Criteria

a. Subject has any condition that in the opinion of the PI preclude enrollment
into the trial.
b. Subject has had a prior RF or cryoablation procedure
c. Subject has predictors for poor regression after ablation therapy, i.e. one
of the following:
* In case of prior ER: regeneration of the ER scar with Barrett*s mucosa, OR
* Active reflux esophagitis grade C or D
* Esophageal narrowing pre-treatment with an estimated diameter <20mm
* Absence of squamous islands in the BE
d. Subject has any significant multisystem diseases.
e. Subject has a body mass index (BMI) greater than 40 kg/m2.
f. Subject has a hiatal hernia > 10cm
g. Subject has known moderate/severe gastroparesis
h. Subject is currently enrolled in other potentially confounding research.
i. Subject has an esophageal stenosis preventing the passage of an endoscope

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath